Mild Dementia
56
12
15
27
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.4%
3 terminated out of 56 trials
90.0%
+3.4% vs benchmark
2%
1 trials in Phase 3/4
19%
5 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 27 completed trials
Clinical Trials (56)
NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Developing and Testing an AI-Based Cognitive Intervention Program
Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia
Effects of Functional Exercises With Culturally Familiar Music in Mild Dementia
Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease
Exploring and Evaluating the Impact of 'Refresh and Reconnect!'
Assessing Cognitive Decline at Home
Transcranial Pulse Stimulation of the Brain
Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly
Brain Health & the Microbiome
Activity Tracking, Care Partner Co-participation, Text Reminders, Instructional Education, Video-Guided Physical Rehabilitation, and Exercise
Care Partner Assisted Intervention to Improve Oral Health of Individuals With Mild Dementia
SHARE Adaptation Intervention for African-American Families
A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)
Atlas of Retinal Imaging in Alzheimer's Study
Promoting In-Home Activities at a Memory & Aging Clinic
The Swedish BioFINDER - Memory Clinic Study
The Swedish BioFINDER - Preclinical AD Study